ChinaBio Today -- Frontage Laboratories Inc., a CRO with facilities in Malvern, PA and Shanghai, will collaborate with Beijing Second Pharmaceuticals, the ethical drug division of Beijing Pharmaceutical Group. Frontage will provide help in developing new generic drugs that will be marketed in China, Europe and the US. The goal is to file 12 abbreviated new drug applications (ANDAs) in the next 3-5 years.
